Western ALS study group

Robert G. Miller, Dan H. Moore, Carlayne E. Jackson, Deborah Gelinas, Richard J. Barohn, April McVey, Art Dick, David Saperstein, Jeffrey Rosenfeld, Mark Bromberg, Jack Petajan, John Ravits, Edward Kasarskis, Hans Neville, Steven Ringel, Dianna Quan, Raul Mandler, E. P. Bosch, Benn Smith, Mark RossMichael Graves, Angela Genge, Catherine Lomen-Hoerth, Richard K. Olney, Alan Pestronk, Paul H. Gordon, David Walk, John Day, Gareth Parry, Jau Shin Lou, Andrew Eisen, Timothy M. Miller, Valerie Cwik, Leo McCluskey, Lauren Elman, Praful Kclkar, Tulio Bertorini, Michael S. McGrath, Jeffrey Elliott, Ramesh Tennore, Barry W. Festoff, Joseph S. Beckman, Jonathan Flax, Dietrich Stephan

Research output: Contribution to journalArticlepeer-review

6 Scopus citations
Original languageEnglish
Pages (from-to)121-124
Number of pages4
JournalAmyotrophic Lateral Sclerosis and Other Motor Neuron Disorders
Volume5
Issue numberSUPPL. 1
DOIs
StatePublished - Sep 2004

Bibliographical note

Funding Information:
The Phase III clinical trial of minocycline has been funded by the National Institutes of Health and the Muscular Dystrophy Association and this study is now underway at 31 centers under the direction of Dr. Paul Gordon at Columbia University, New York.

ASJC Scopus subject areas

  • Clinical Neurology

Cite this